CNTX - Context Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNTX is currently covered by 1 analysts with an average price target of $4.81. This is a potential upside of $3.92 (440.45%) from yesterday's end of day stock price of $0.89.

Context Therapeutics's activity chart (see below) currently has 2 price targets and 10 ratings on display. The stock rating distribution of CNTX is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Highest price target for CNTX is $6, Lowest price target is $6, average price target is $6.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 23-Sep-2024. First documented stock forecast 02-Feb-2022.

Best performing analysts who are covering CNTX - Context Therapeutics:

Emily Bodnar

Currently out of the existing stock ratings of CNTX, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Emily Bodnar (HC WAINWRIGHT)

Buy

$4.99 (494.06%)

10 months 30 days ago
(23-Sep-2024)

0/8 (0%)

$3.92 (188.46%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is CNTX (Context Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CNTX (Context Therapeutics) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on CNTX (Context Therapeutics)?

Emily Bodnar works at HC WAINWRIGHT and has 1 price targets and 2 ratings on CNTX

Which analyst is the currently most bullish on CNTX (Context Therapeutics)?

Emily Bodnar with highest potential upside - $4.99